Adipose-Derived Stem Cell–Enriched Lipotransfer Reverses Skin Sclerosis by Suppressing Dermal Inflammation

W Jiang, J Wang, J Lin, S Jiang, Y Quan… - Plastic and …, 2022 - journals.lww.com
Background: Scleroderma is a chronic autoimmune disease with an incidence of 2.7 per
100,000 people. Traditional lipotransfer has been used to treat atrophic sclerotic skin …
被引用次数：9 相关文章

Adipose-Derived Stem Cell–Enriched Lipotransfer Reverses Skin Sclerosis by Suppressing Dermal Inflammation

W Jiang, J Wang, J Lin, S Jiang, Y Quan… - Plastic and …, 2022 - journals.lww.com
Background: Scleroderma is a chronic autoimmune disease with an incidence of 2.7 per
100,000 people. Traditional lipotransfer has been used to treat atrophic sclerotic skin …

Adipose-Derived Stem Cell-Enriched Lipotransfer Reverses Skin Sclerosis by Suppressing Dermal Inflammation

W Jiang, J Wang, J Lin, S Jiang… - Plastic and …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Scleroderma is a chronic autoimmune disease with an incidence of 2.7 per
100,000 people. Traditional lipotransfer has been used to treat atrophic sclerotic skin …

Adipose-Derived Stem Cell-Enriched Lipotransfer Reverses Skin Sclerosis by Suppressing Dermal Inflammation.

W Jiang, J Wang, J Lin, S Jiang, Y Quan… - Plastic and …, 2022 - europepmc.org
Background Scleroderma is a chronic autoimmune disease with an incidence of 2.7 per
100,000 people. Traditional lipotransfer has been used to treat atrophic sclerotic skin …

Adipose-Derived Stem Cell–Enriched Lipotransfer Reverses Skin Sclerosis by Suppressing Dermal Inflammation

W Jiang, J Wang, J Lin, S Jiang, Y Quan… - Plastic and …, 2022 - ingentaconnect.com
Background: Scleroderma is a chronic autoimmune disease with an incidence of 2.7 per
100,000 people. Traditional lipotransfer has been used to treat atrophic sclerotic skin …